{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:13:53Z","timestamp":1789168433127,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1331\/japha.2014.14011","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T18:32:39Z","timestamp":1406313159000},"page":"441-445","source":"Crossref","is-referenced-by-count":15,"title":["How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak"],"prefix":"10.1016","volume":"54","author":[{"given":"Besu F.","family":"Teshome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Reveles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurajo","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2014.14011_bb0010","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1213978","article-title":"Fungal infections associated with contaminated methylprednisolone injections","volume":"369","author":"Smith","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1331\/JAPhA.2014.14011_bb0015","unstructured":"Centers for Disease Control and Prevention.\u00a0Multistate meningitis outbreak\u2014current case count.\u00a0www.cdc.gov\/hai\/outbreaks\/meningitis-map-large.html.\u00a0Accessed\u00a0July 5, 2014."},{"issue":"41","key":"10.1331\/JAPhA.2014.14011_bb0020","first-page":"839","article-title":"Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy\u2014United States, 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2014.14011_bb0025","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1086\/592968","article-title":"Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy","volume":"47","author":"Gershman","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1331\/JAPhA.2014.14011_bb0030","first-page":"310","article-title":"Notes from the field: multistate outbreak of postprocedural fungal endophthalmitis associated with a single compounding pharmacy\u2014United States, March\u2013April 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2014.14011_bb0035","unstructured":"New England Compounding Center customer list as of May 21, 2012. www.fda.gov\/downloads\/Drugs\/DrugSafety\/FungalMeningitis\/UCM325467.pdf. Accessed May 1, 2013."},{"key":"10.1331\/JAPhA.2014.14011_bb0040","author":"Smith"},{"key":"10.1331\/JAPhA.2014.14011_bb0045","unstructured":"United States Pharmacopeia. USP on compounding: a guide for the compounding practitioner. www.usp.org\/store\/products-services\/usp-compounding. Accessed April 1, 2014."},{"key":"10.1331\/JAPhA.2014.14011_bb0050","unstructured":"U.S. House of Representatives, Energy & Commerce Committee. The fungal meningitis outbreak: could it have been prevented? November 14, 2012. energycommerce.house.gov\/hearing\/fungal-meningitis-outbreak-could-it-have-been-prevented. Accessed May 1, 2013."},{"issue":"17 Suppl 5","key":"10.1331\/JAPhA.2014.14011_bb0055","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2146\/ajhp0108b","article-title":"Pharmacy compounding of high-risk level products and patient safety","volume":"66","author":"Mullarkey","year":"2009","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1331\/JAPhA.2014.14011_bb0060","doi-asserted-by":"crossref","first-page":"e7432","DOI":"10.1136\/bmj.e7432","article-title":"Meningitis outbreak shines light on compounding pharmacies","volume":"345","author":"Shaughnessy","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1331\/JAPhA.2014.14011_bb0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1378\/chest.13-0212","article-title":"Compounding pharmacy conundrum: \u201cwe cannot live without them but we cannot live with them\u201d according to the present paradigm","volume":"143","author":"Guharoy","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1331\/JAPhA.2014.14011_bb0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0897190010366928","article-title":"Regulation of compounding by the Food and Drug Administration: a tale of 2 circuits","volume":"23","author":"Williams","year":"2010","journal-title":"J Pharm Pract"},{"key":"10.1331\/JAPhA.2014.14011_bb0075","unstructured":"Food and Drug Administration Modernization Act of 1997. www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/PharmacyCompounding\/ucm155666.htm. Accessed July 5, 2014."},{"key":"10.1331\/JAPhA.2014.14011_bb0080","unstructured":"Food and Drug Administration.\u00a0Compliance Policy Guide Section 460.200 Pharmacy Compounding (Reissued 05\/29\/2002).\u00a0www.fda.gov\/ohrms\/dockets\/98fr\/02d-0242_gdl0001.pdf.\u00a0Accessed\u00a0July 5, 2014."},{"key":"10.1331\/JAPhA.2014.14011_bb0085","unstructured":"Drug Quality and Security Act of 2013.\u00a0H.R. 3204.\u00a0beta.congress.gov\/bill\/113th-congress\/house-bill\/3204.\u00a0Accessed\u00a0July 15, 2014."},{"key":"10.1331\/JAPhA.2014.14011_bb0090","unstructured":"U.S. Food and Drug Administration. FDA implementation of the Compounding Act. www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/PharmacyCompounding\/ucm375804.htm. Accessed December 2, 2013."},{"key":"10.1331\/JAPhA.2014.14011_bb0095","author":"U.S. Federal Register"},{"issue":"1","key":"10.1331\/JAPhA.2014.14011_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2146\/news140002","article-title":"President signs compounding law","volume":"71","author":"Traynor","year":"2014","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1331\/JAPhA.2014.14011_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2146\/news130010","article-title":"FDA, states discuss pharmacy compounding regulatory framework","volume":"70","author":"Traynor","year":"2013","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"10.1331\/JAPhA.2014.14011_bb0110","first-page":"25","article-title":"State boards and NABP take action to clarify regulation and bolster state regulatory systems specific to compounding pharmacies","volume":"42","author":"Anonymous","year":"2013","journal-title":"National Association of Boards of Pharmacy Newsletter"},{"key":"10.1331\/JAPhA.2014.14011_bb0115","author":"Food and Drug Administration"},{"key":"10.1331\/JAPhA.2014.14011_bb0120","series-title":"Framingham Patch","article-title":"Judge tells NECC don't destroy, tamper with anything, consolidates lawsuits. Framingham Patch","author":"Petroni","year":"2012"},{"key":"10.1331\/JAPhA.2014.14011_bb0125","author":"Wilemon"},{"key":"10.1331\/JAPhA.2014.14011_bb0130","author":"Wallack"},{"key":"10.1331\/JAPhA.2014.14011_bb0135","author":"Massachusetts Department of Public Health"},{"key":"10.1331\/JAPhA.2014.14011_bb0140","author":"Massachusetts cracks down on compounding pharmacies"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911530220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911530220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T05:59:31Z","timestamp":1538373571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431911530220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S154431911530220X"],"URL":"https:\/\/doi.org\/10.1331\/japha.2014.14011","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}